Literature DB >> 25180561

Development and validation of the opioid prescription medication motives questionnaire: a four-factor model of reasons for use.

Rachel E Jones1, Alexander Spradlin1, R Joe Robinson1, Sarah L Tragesser1.   

Abstract

There is considerable evidence that understanding reasons for using substances is important for understanding patterns of use and related consequences as well as for developing assessment and intervention strategies. Despite increases in prescription opioid use and related problems (e.g., overdose deaths), a comprehensive measure of prescription opioid motives has yet to be developed. As such, the current study sought to develop and provide validation evidence for a measure of prescription opioid motives. One hundred eleven male and 226 female undergraduate students completed an initial pool of motive items based on the current literature and measures of prescription opioid use and related problems. Confirmatory factor analysis results demonstrated that the predicted 4-factor model provided a good fit to the data. The 4 motives-pain, social, enhancement, and coping-each showed differential patterns of associations with prescription opioid-related contextual and use variables. Enhancement motives were associated with quantity of use (past 3 months and maximum use in 1 day), frequency of use, in multiple contexts, misuse, and related problems. Coping motives demonstrated relations with maximum pills (in 1 day), frequency of use, and prescription opioid misuse, consequences, and dependence features. For social motives, significant associations were found with frequency of use (in past 3 months), typical number of pills (in 1 day), dependence features, and use both on weekdays and on weekends; this motive had a negative association with maximum number of pills taken in 1 day. Pain motives were largely related to frequency of use (in past 3 months), consequencess, and dependence features. The present study is the first to present an empirical measure of prescription opioid motives and demonstrates how these motives have important implications for understanding patterns of prescription opioid use and related problems.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25180561     DOI: 10.1037/a0037783

Source DB:  PubMed          Journal:  Psychol Addict Behav        ISSN: 0893-164X


  9 in total

1.  Coping motives mediate the relationship between borderline personality features and alcohol, cannabis, and prescription opioid use disorder symptomatology in a substance use disorder treatment sample.

Authors:  Noel A Vest; Sarah Tragesser
Journal:  Personal Disord       Date:  2019-12-09

2.  Alcohol use disorder and motives for prescription opioid misuse: A latent class analysis.

Authors:  Victoria R Votaw; R Kathryn McHugh; Katie Witkiewitz
Journal:  Subst Use Misuse       Date:  2019-05-07       Impact factor: 2.164

3.  Examining replicability in addictions research: How to assess and ways forward.

Authors:  Matthew R Pearson; Frank J Schwebel; Dylan K Richards; Katie Witkiewitz
Journal:  Psychol Addict Behav       Date:  2021-08-26

4.  Are Pain and Negative Affect Coping Distinct Motives for Opioid Misuse?

Authors:  R Kathryn McHugh; Alexandra Chase; Catherine D Trinh; Roger D Weiss
Journal:  Subst Use Misuse       Date:  2022-03-08       Impact factor: 2.362

5.  Racial-ethnic Differences in Reasons for Misuse of Prescription Medications Among US Adults.

Authors:  James D Cury; Vinita Sharma; Alyssa M Falise; Ellen L Terry; Catalina Lopez-Quintero
Journal:  J Addict Med       Date:  2021-11-12       Impact factor: 4.647

6.  Understanding Drinking Game Behaviors: A Consideration of Alcohol Expectancies and Motives to Play and Drink.

Authors:  Byron L Zamboanga; Minyu Zhang; Janine V Olthuis; Su Yeong Kim
Journal:  Cognit Ther Res       Date:  2017-12-29

7.  The CannTeen study: verbal episodic memory, spatial working memory, and response inhibition in adolescent and adult cannabis users and age-matched controls.

Authors:  W Lawn; N Fernandez-Vinson; C Mokrysz; G Hogg; R Lees; K Trinci; K Petrilli; A Borissova; S Ofori; S Waters; P Michór; M B Wall; T P Freeman; H V Curran
Journal:  Psychopharmacology (Berl)       Date:  2022-04-29       Impact factor: 4.415

8.  Nonmedical Prescription Opioid Use among a Sample of College Students: Prevalence and Predictors.

Authors:  Lisa L Weyandt; Bergljót Gyda Gudmundsdottir; Emily Shepard; Leslie Brick; Ashley Buchanan; Christine Clarkin; Alyssa Francis; Marisa Marraccini
Journal:  Pharmacy (Basel)       Date:  2021-05-28

9.  Negative affect-associated drug refusal self-efficacy, illicit opioid use, and medication use following short-term inpatient opioid withdrawal management.

Authors:  Jumi Hayaki; Micah T Conti; Genie L Bailey; Debra S Herman; Bradley J Anderson; Michael D Stein
Journal:  J Subst Abuse Treat       Date:  2021-01-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.